Low-Dose Naltrexone (LDN): Clinical Evidence for Chronic Illness and Autoimmunity
Low-dose naltrexone modulates immune function and reduces neuroinflammation. Evidence-based overview of LDN dosing, mechanisms, and clinical applications.
Clinical Immunology
Moderate EvidenceMolecular mimicry, tolerance breakdown, and integrative approaches to autoimmune conditions.
Low-dose naltrexone modulates immune function and reduces neuroinflammation. Evidence-based overview of LDN dosing, mechanisms, and clinical applications.
How extracorporeal apheresis reduces autoantibody burden, inflammatory cytokines, and immune complex load in treatment-resistant autoimmune conditions.
Why the immune system attacks itself, what triggers autoimmunity, and how integrative medicine approaches treatment. By Dr. Julian Douwes.